Pfizer, Inc. (PFE) Tops Q3 EPS by 7c; Raises Buyback Target to $7-$9B; Reaffirms Outlook
November 1, 2011 7:01 AM
Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.62, $0.07 better than the analyst estimate of $0.55. Revenue for the quarter came in at $17.2 billion versus the consensus estimate of $16.43 billion.
